TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Merck Life Science A/S
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 | 
| Turnover | 187,664 | 168,913 | 135,631 | 
| Earnings before taxes | 12,700 | 7,832 | 6,914 | 
| Total assets | 43,295 | 31,358 | 33,604 | 
| Current assets | 43,086 | 30,937 | 32,973 | 
| Current liabilities | 11,087 | 8,909 | 4,594 | 
| Equity capital | 32,183 | 22,356 | 28,871 | 
| - share capital | 268 | 269   | 269 | 
| Employees (average) | 7   | 7   | 7 | 
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 | 
| Solvency | 74.3% | 71.3% | 85.9% | 
| Turnover per employee | 26,809 | 24,130 | 19,376 | 
| Profit as a percentage of turnover | 6.8% | 4.6% | 5.1% | 
| Return on assets (ROA) | |||
| Current ratio | 388.6% | 347.3% | 717.7% | 
| Return on equity (ROE) | 39.5% | 35.0% | 23.9% | 
| Change turnover | 19,127 | 33,281 | 32,328 | 
| Change turnover % | 11% | 25% | 31% | 
| Chg. No. of employees | 0   | 0   | 0 | 
| Chg. No. of employees % | 0%   | 0%   | 0% | 
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 | 
| Total value of public sale | 0   | 0   | 0 | 
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.
 
         
                    